Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3211-3220

  Tinley, Tina L ^a   Randall Hlubek, Deborah A ^a   Leal, Rachel M ^a   Jackson, Evelyn M ^a   Cessac, James W ^b   Quada Jr , James C ^a,d   Hemscheidt, Thomas K ^c   Mooberry, Susan L ^a,e  

^a Depts of Physiology and Medicine   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d TransTech Pharma Inc   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA TUBULIN; GLYCOPROTEIN P; MICROTUBULE STABILIZING AGENT; PACLITAXEL; PHYTOSTEROL; PLANT EXTRACT; PROTEIN BCL 2; TACCA CHANTRIERI EXTRACT; TACCALONOLIDE A; TACCALONOLIDE E; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL LINE; CELL PROLIFERATION; CROSS RESISTANCE; DRUG ACTIVITY; DRUG BINDING SITE; DRUG EFFECT; DRUG POTENCY; DRUG RESISTANCE; DRUG SCREENING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; INTERPHASE; MEDICINAL PLANT; MICROTUBULE; MITOSIS; MITOSIS SPINDLE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TACCA CHANTRIERI;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOPOLYMERS; BREAST NEOPLASMS; CELL NUCLEUS; CELLS, CULTURED; CENTROSOME; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; INTERPHASE; MAP KINASE SIGNALING SYSTEM; MICROTUBULE PROTEINS; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; MOLECULAR STRUCTURE; MUSCLE, SMOOTH; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RHIZOME; STEROIDS; TUMOR CELLS, CULTURED;

EID: 0037731512     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
2. Derry, W. B., Wilson, L., and Jordan, M. A Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry, 34: 2203-2211, 1995.
3. Jordan, M. A., Wendell, K., Gardiner, S., Derry, w. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
4. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., and Huang, Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore). 7: 563-568, 1993.
5. Rowinsky, E. K. The development and clinical utility of the laxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 48: 353-374, 1997.
6. Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E., and Woods, C. M. Epothilones, a new class of microtubulstabilizing agents with a taxol-like mechanism of action. Cancer Res., 55: 2325-2333, 1995.
7. Kowalski, R. J., Giannakakou, P., and Hamel, E. Activities of the microtubulestabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®). J. Biol. Chem., 272: 2534-2541, 1997.
8. Altmann, K. H., Wartmann, M., and O'Reilly, T. Epothilones and related structures: a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim. Biophys. Acta, 1470: M79-M91, 2000.
9. ter Haar, E., Kowalski, R. J., Hamel, E., Lin, C. M., Longley, R. E., Gunasekera, S. P., Rosenkranz, H. S., and Day, B. W. Discodermolide, a cytotoxic murine agent that stabilizes microtubules more potently than taxol. Biochemistry, 35: 243-250, 1996.
10. Kowalski, R. J., Giannakakou, P., Gunasekera, S. P., Longley, R. E., Day, B. W., and Hamel, E. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol. Pharmacol., 52: 613-622, 1997.
11. Long, B. H., Carboni, J. M., Wasserman, A. J., Cornell, L. A., Casazza, A. M., Jensen, P. R., Lindel, T., Fenical, W., and Fairchild, C. R. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). Cancer Res., 58: 1111-1115, 1998.
12. Hamel, E., Sackett, D. L., Vourloumis, D., and Nicolaou, K. C. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry, 38: 5490-5498, 1999.
13. Mooberry, S. L., Tien, G., Hernandez, A. H., Plubrukarn, A., and Davidson, B. S. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res., 59: 653-660, 1999.
14. Hood, K. A., West, L. M., Rouwe, B., Northcote, P. T., Berridge, M. V., Wakefield, S. J., and Miller, J. H. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res., 62: 3356-3360, 2002.
15. Pyor, D. E., O'Brate, A., Bilcer, G., Diaz, J. F., Wang, Y., Kabaki, M., Jung, M. K., Andreu, J. M., Ghosh, A. K., Giannakakou, P., and Hamel, E. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry, 41: 9109-9115, 2002.
16. Chen, Z-L., Wang, B-D., and Chen, M-Q. Steroidal bilter principles from Tacca plantaginea. Structures of taccalonolide A and B. Tetrahadron Lett., 28: 1673-1678, 1987.
17. Shen, J. Chen, Z., and Gao, Y. The pentacyclic steroidal constituents of Tacca plantaginea: taccalonolide E and F. Chinese J. Chem., 9: 92-94, 1991.
18. Muhlbauer, A., Gehling, M., Velten, R., Andersch, W., Erdelen, C., Harder, A., Marczok, P., Nauen, R., Turberg, A., TranVan, S., Adam, G., and Liu, J. Taccalonolides and their use. World Intellectual Properly Organization Patent No. WO 01 40256 A1, 2001.
19. Scudiero, D. A., Monks, A., and Sausville, E. A. Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. J. Natl. Cancer Inst. (Bethesda), 90: 862, 1998.
20. Skehan, P., Storeng, R., Scodiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cyyotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990.
21. Boyd, M. R., and Paull, K. D. Some practical considerations and applications of the National Cancer Institute in vitro anticancer discovery screen. Drug Dev. Res., 34: 91-109, 1995.
22. Mooberry, S. L., Busquets, L., and Tien, G. Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent. Int. J. Cancer, 73: 440-448, 1997.
23. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188-193, 1975.
24. Giannakakou, P., Sackett, D. L., Kang, Y. K., Zhan, Z., Bulers, J. T., Fojo, T., and Poruchynsky, M. S. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem., 272: 17118-17125, 1997.
25. Giannakakou, P., Gussio, R., Nogales, E., Downing, K. H., Zaharevitz, D., Bollbuck, B., Poy, G., Sackett, D., Nicolaou, K. C., and Fojo, T. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl. Acad. Sci USA. 97: 2904-2909, 2000.
26. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorezyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
27. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
28. Mooberry, S. L., Leal, R. M., Tinley, T. L., Luesch, H., Moore, R. E., and Corbett, T. H. The molecular pharmacology of symplostatin I: a new antimitotic dolastatin 10 analog. Int. J. Cancer, 104: 512-521, 2003.
29. Haldar, S., Basu, A., and Croce, C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57: 229-233, 1997.
30. Yang, C. P., and Horwitz, S. B. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Res., 60: 5171-5178, 2000.
31. Yang, C. P., and Horwitz, S. B. Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells. Biochim. Biophys. Acta, 1590: 76-83, 2002.
32. Blagosklonny, M. V., Giannakakou, F., el-Deiry, W. S., Kingston, D. G., Higgs, P. I., Neckers, L., and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57: 130-135, 1997.
33. McDaid, H. M., and Horwitz, S. B. Selective potentiation of paclitaxel (Taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol. Pharmacol., 60: 290-301, 2001.
34. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazehnik, Y. A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
35. Duriez, P. J., and Shah, G. M. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol., 75: 337-349, 1997.
36. Verdier-Pinard, P., Wang, Z., Mohanakrishnan, A. K., Cushman, M., and Hamel, E. A steroid derivative with paclitaxel-like effects on tubulin polymerization. Mol. Pharmacol., 57: 568-575, 2000.
37. Wilson, L., and Jordan, M. A. Microtubule dynamics: taking aim at a moving target. Chem. Biol., 2: 569-573, 1995.
38. Rusan, N. M., Fagerstrom, C. J., Yvon, A. M., and Wadsworth, P. Cell cycle-dependent changes in microtubule dynamics in living cells expressing green fluorescent protein-α tubulin. Mol. Biol. Cell, 12: 971-980, 2001.
39. Chen, J. G., and Horwitz, S. B. Differential mitotic reponses to microtubule stabilizing and -destabilizing drugs. Cancer Res., 62: 1935-1938, 2002.
40. Blagosklonny, M. V., and Fojo, T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer, 83: 151-156, 1999.
41. Lobert, S., Fahy, J., Hill, B. T., Duflos, A., Etievant, C., and Correia, J. J. Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxieity in the leukemic L1210 cell line. Biochemistry, 39: 12053-12062, 2000.
42. Kruczynski, A., and Hill, B. T. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit. Rev. Oncol. Hematol., 40: 159-173, 2001.
43. Chou, T. C., Zhang, X. O., Harris, C. R., Kuduk, S. D., Balog, K. A., Savin, K. A., Bertino, J. R., and Danishefsky, S. J. Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. Proc. Natl. Acad. Sci. USA, 95: 15798-15802, 1998.
44. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scadiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J., Jr., and Kohn, K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57: 4285-4300, 1997.
45. Martello, L. A., McDaid, H. M., Regl, D. L., Yang, C-P. H., Meng, D., Pettus, T. R. R., Kaulman, M. D., Arimoto, H., Danishefski, S. J., Smith, A. B., III, and Horwitz, S. B. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin. Cancer Res., 6: 1978-1987, 2000.
46. Giannakakou, P., and Fojo, T. Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy. Clin. Cancer Res., 6: 1613-1615, 2000.